TSINY

Tsumura & Co. is the world's leading pharmaceutical company specializing in Kampo medicine, traditional Japanese herbal remedies standardized for modern clinical use. The company holds a dominant market share of over 80% in the prescription Kampo market in Japan and is a pioneer in integrating traditional treatments into evidence-based medicine (EBM-Kampo). Tsumura's business model is vertically integrated, encompassing the cultivation of medicinal plants, high-tech standardized extraction processes, and rigorous clinical validation. Key therapeutic focuses include oncology supportive care, gastroenterology, and geriatric health, with flagship products like Daikenchuto undergoing global clinical trials. The company is increasingly expanding its footprint in China and the United States to globalize standardized botanical therapies.